Ethicon Inc is looking forward to seeing you at the 2017 Women in Engineering Leadership Summit in Cincinnati, Ohio.
Those selected for attendance at the summit receive:
Ethicon Inc, part of the Johnson & Johnson family of companies, develops and markets advanced medical devices for minimally invasive and open surgical procedures. The company focuses on procedure-enabling devices in general and bariatric surgery, gastrointestinal health, gynecology and surgical oncology. Some products in the portfolio include: the ENDOPATH® XCEL™ Access System; ECHELON FLEXTM Powered ENDOPATH® Stapler; HARMONIC™ ultrasonic cutting and coagulating surgical devices; and ENSEAL® RF cutting and coagulating surgical devices.
As a co-op at Ethicon, Inc you will have the opportunity to:
We offer competitive wage and subsidized, furnished housing for non-local students. The co-op opportunity includes positions within Product Management, R&D Design, Development, and Quality and provides each student with a great support system, as well as the opportunity to meet people from various schools throughout the country.
Although all opportunities may vary in minimum qualifications, all at a minimum require:
· Must be currently enrolled in a degreed Engineering program with some completed engineering courses.
· Unlimited Legal Authorization to work in the U.S. is required
· Maintain a minimum overall GPA of 3.0 without rounding
· Targeting, 2019 & 2020 graduates.
Further Information about Johnson & Johnson
At Johnson & Johnson, we strive to provide a climate where people of all backgrounds and experiences can make meaningful contributions to the future of healthcare. It's a rich culture of inclusion and diversity, reflecting the international nature of our business.
Johnson & Johnson can provide career opportunities in all 3 sectors; Pharmaceutical, Consumer and Medical Device.
Johnson & Johnson is one of the most comprehensive devices businesses in the industry. Our medical devices business is best suited to serve evolving customer needs, train more surgeons to improve standards of care, and treat more patients globally as access expands. We will achieve this by accelerating our growth in key platforms and geographies, advancing our innovation, leveraging our breadth/scale, reduce cost to serve and evolving our go-to-market models.